Pancreatic Cancer Research

ResearcherFlorida Agricultural and Mechanical UniversityActive in the last 2 years

Nazarius Saah Lamango

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4906-8933; OpenAlex author ID A5013398839. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. The anticancer effects of PCAIs in pancreatic cancer cells involve MAPK and PI3K/AKT pathways hyperactivation. Last author DOI 10.18632/oncotarget.28879↗
  2. Disruption of actin filaments and suppression of pancreatic cancer cell viability and migration following treatment with polyisoprenylated cysteinyl amides. Last author PMID 27904769↗
  3. Polyisoprenylated methylated protein methyl esterase: a putative biomarker and therapeutic target for pancreatic cancer. Last author DOI 10.1016/j.ejmech.2014.05.018↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kweku Ofosu-Asante · 1 shared paper, 2026 · strength 0.43
  2. Augustine T. Nkembo · 2 shared papers, 2014–2016 · strength 0.11
  3. Hernan Alcides Flores-Rozas · 1 shared paper, 2016 · strength 0.07
  4. Byron J. Aguilar · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.